These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6958522)
1. Mathematical modelling and clinical trials. Jackson RR; Hughes DJ Experientia Suppl; 1982; 41():327-37. PubMed ID: 6958522 [No Abstract] [Full Text] [Related]
2. On choosing the number of interim analyses in clinical trials. McPherson K Experientia Suppl; 1982; 41():454-68. PubMed ID: 6958530 [No Abstract] [Full Text] [Related]
3. Use of prognostic factors in analysis of historical control studies. Gehan EA; Smith TL; Buzdar AU Cancer Treat Rep; 1980; 64(2-3):373-9. PubMed ID: 7407774 [TBL] [Abstract][Full Text] [Related]
4. Size of phase III cancer clinical trials. Simon R Cancer Treat Rep; 1985 Oct; 69(10):1087-93. PubMed ID: 4042088 [No Abstract] [Full Text] [Related]
5. Comparative clinical trials with historical controls: a statistician's view. Gehan EA Biomedicine; 1978 Sep; 28 Spec No():13-9. PubMed ID: 363189 [No Abstract] [Full Text] [Related]
6. Performing serial testing of treatment effects. Fleming TR; Green SJ; Harrington DP Experientia Suppl; 1982; 41():469-84. PubMed ID: 6958531 [No Abstract] [Full Text] [Related]
7. The scientific basis of clinical trials: statistical aspects. Gehan EA Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661 [TBL] [Abstract][Full Text] [Related]
8. Knowledge acquisition from historical data: application to breast cancer patients. Gehan EA; Smith TL; Buzdar AU; Keating MJ; Freireich EJ Bull Cancer; 1980; 67(4):437-45. PubMed ID: 7013864 [TBL] [Abstract][Full Text] [Related]
9. [Cancer immunotherapy]. Kaartinen M; Mäkelä O Duodecim; 1976; 92(24):1364-9. PubMed ID: 1070434 [No Abstract] [Full Text] [Related]
10. Clinical trials of human leukocyte interferon in malignancy. Hill NO; Pardue A; Khan A; Aleman C; Hilario R; Hill JM Tex Rep Biol Med; 1981-1982; 41():634-40. PubMed ID: 6763370 [No Abstract] [Full Text] [Related]
11. Exercise and cancer: no pain, some gain? Rayson D; Reyno L J Clin Oncol; 2003 May; 21(9):1651-2. PubMed ID: 12721237 [No Abstract] [Full Text] [Related]
12. [Breast cancer. Methods in intensely criticized research project]. Vesterdal A Sygeplejersken; 1988 Sep; 88(38):9. PubMed ID: 3217862 [No Abstract] [Full Text] [Related]
14. Administration of prostaglandins A and E and antiinflammatory drugs to patients with cancer. Powles TJ Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():327-31. PubMed ID: 6133423 [No Abstract] [Full Text] [Related]
15. Fads and fashions of early breast cancer clinical trials in the United States over the past decade (1971-1981). Gelman R Experientia Suppl; 1982; 41():520-41. PubMed ID: 6958535 [No Abstract] [Full Text] [Related]
16. Can underpowered clinical trials be justified? Rosoff PM IRB; 2004; 26(3):16-9. PubMed ID: 15281196 [No Abstract] [Full Text] [Related]
17. Clinical trials referral resource. Clinical trials in elderly patients. Cheson BD; Nelson A Oncology (Williston Park); 1997 Jun; 11(6):838, 844. PubMed ID: 9189940 [No Abstract] [Full Text] [Related]
18. Assessment of response and recurrence in breast cancer. Hayward JL; Meakin JW; Stewart HJ Semin Oncol; 1978 Dec; 5(4):445-9. PubMed ID: 366756 [No Abstract] [Full Text] [Related]
19. Modelling competing risks in cancer studies. Klein JP Stat Med; 2006 Mar; 25(6):1015-34. PubMed ID: 16435339 [TBL] [Abstract][Full Text] [Related]